Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 559 News Items found In the Lab Experimental Drug Targets Misbehaving Proteins in Brain Cancer and Alzheimer’s Disease Tuesday, August 3, 2021 Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease. Q&A CAR T Cell Therapy Shows Promise for Treating Mesothelioma Thursday, July 29, 2021 A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma. Brown Fat — Which Warms Babies and Bears — Protects Against Harmful Aspects of Obesity, Study Finds Tuesday, July 13, 2021 People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering. Feel the Burn: Researchers Identify Fat Storage Protein That Could Be Key to Alleviating Obesity Thursday, July 8, 2021 Researchers discover how immune cells called macrophages regulate whether fat is stored or burned. MSK Scientists Reveal Biology of Shape-Shifting Lung Cancer Wednesday, July 7, 2021 Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes. Feature How MSK-ACCESS Blood Test for Cancer was Created Thursday, July 1, 2021 MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK. In the Lab Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective Thursday, June 24, 2021 In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better. Scientists Obtain Real-Time Look at How Cancers Evolve Wednesday, June 23, 2021 With the help of machine learning, computational biologists are learning to predict how cancers will evolve. Finding Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment Wednesday, June 16, 2021 An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations. MSK Scientists Solve One of TB’s Deadliest Tricks Tuesday, June 15, 2021 Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses. Pagination First page « First Previous page ‹ Previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page Next › Last page Last »